Global Tech Times
SEE OTHER BRANDS

The best science and technology news from the world

Global Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Times.

Press releases published on June 5, 2025

Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan

Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan

Sanofi Launches 2025 Global Employee Stock Purchase Plan Paris, June 5, 2025. Sanofi’s global employee shareholder plan, Action 2025, opens on June 10, 2025, to around 70,000 employees in 55 countries. Now in its 11th year, the program demonstrates the …

Communiqué de presse : Sanofi lance son plan mondial 2025 d’actionnariat salarié

Communiqué de presse : Sanofi lance son plan mondial 2025 d’actionnariat salarié

Sanofi lance son plan mondial 2025 d’actionnariat salarié Paris, le 5 juin 2025. Sanofi lance Action 2025, son plan mondial d’actionnariat salarié, qui sera ouvert le 10 juin 2025 à environ 70 000 salariés dans 55 pays. Ce plan, qui entre dans sa onzième …

SPEC Resumes Global Collaboration with Companies on U.S. BIS Entity List

SPEC Resumes Global Collaboration with Companies on U.S. BIS Entity List

GAINESVILLE, Va., June 05, 2025 (GLOBE NEWSWIRE) -- Standard Performance Evaluation Corp. (SPEC), the trusted leader in computing benchmarks, announced today that SPEC International Standards Group (ISG) successfully advocated that the United States …

Atos fournira les services et applications informatiques clés pour l'UEFA Nations League Finals™ 2025

Atos fournira les services et applications informatiques clés pour l'UEFA Nations League Finals™ 2025

                                                                Communiqué de presse Atos fournira les services et applications informatiques clés pour l'UEFA Nations League Finals™ 2025 Paris, France – le 5 juin 2025 – Atos, partenaire informatique …

Atos to deliver key IT services and applications for UEFA Nations League Finals™ 2025

Atos to deliver key IT services and applications for UEFA Nations League Finals™ 2025

                                                                Press Release Atos to deliver key IT services and applications for UEFA Nations League Finals™ 2025 Paris, France – 5 June, 2025 – Atos, the Official Information Technology Partner of UEFA …

CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle

CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle

Lehi, June 05, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 5, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform designed to use the body’s immune system to treat cancer, today announced the successful creation …

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)

HYDERABAD, India and REYKJAVIK, Iceland, June 05, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s …

SandCo Sets New Quartz Sand Production Record with 15,000 Tons in 2024, Eyes Further Expansion into China Market and Critical Minerals

SandCo Sets New Quartz Sand Production Record with 15,000 Tons in 2024, Eyes Further Expansion into China Market and Critical Minerals

LONDON and ASTANA, Kazakhstan, June 05, 2025 (GLOBE NEWSWIRE) -- SandCo, Central Asia's top-tier supplier of premium quartz sand, reported an unprecedented production total of 15,000 tons for 2024 due to an initial $10 million investment in extended …

Juvenescence acquires AI drug discovery company Ro5 to boost R&D capabilities and drive pipeline of medicines to extend healthy lifespan

Juvenescence acquires AI drug discovery company Ro5 to boost R&D capabilities and drive pipeline of medicines to extend healthy lifespan

Ro5 Inc. acquisition enhances artificial intelligence/machine learning drug discovery capabilities Strategic addition strengthens Juvenescence’s AI-enabled therapeutics pipeline and supports partnership with M42 (Mubadala) Acquisition follows $76m Series B …

VALLOUREC OBTAINS THE QUALIFICATION OF ITS HYDROGEN STORAGE SOLUTION AND LAUNCHES COMMERCIALIZATION

VALLOUREC OBTAINS THE QUALIFICATION OF ITS HYDROGEN STORAGE SOLUTION AND LAUNCHES COMMERCIALIZATION

Press Release VALLOUREC OBTAINS THE QUALIFICATION OF ITS HYDROGEN STORAGE SOLUTION AND LAUNCHES COMMERCIALIZATION Meudon (France), June 5, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces the official qualification of  …

VALLOUREC OBTIENT LA QUALIFICATION DE SA SOLUTION DE STOCKAGE D’HYDROGÈNE ET LANCE SA COMMERCIALISATION

VALLOUREC OBTIENT LA QUALIFICATION DE SA SOLUTION DE STOCKAGE D’HYDROGÈNE ET LANCE SA COMMERCIALISATION

Communiqué de presse VALLOUREC OBTIENT LA QUALIFICATION DE SA SOLUTION DE STOCKAGE D’HYDROGÈNE ET LANCE SA COMMERCIALISATION Meudon (France), le 5 juin 2025 – Vallourec, leader mondial des solutions tubulaires premium sans soudure, annonce la qualification …

Starke Verkaufszahlen für Cresemba® (Isavuconazol) in der Region Asien-Pazifik und China lösen weitere Meilensteinzahlung an Basilea aus

Starke Verkaufszahlen für Cresemba® (Isavuconazol) in der Region Asien-Pazifik und China lösen weitere Meilensteinzahlung an Basilea aus

Allschwil, 05. Juni 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch Bakterien oder Pilze erkrankt sind, gab …

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea

Allschwil, Switzerland, June 05, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued …

 AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology

AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology

Third asset to advance into clinical trials, validating broad potential of Launch-iT platform All subjects treated with first dose of AVX70371 Launch-iT, as part of multiple dosing schedule Potential first-in-class treatment that could form part of …

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference 

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference 

Geneva, Switzerland, June 5, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that …

NET POWER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NET Power Inc. - NPWR

NET POWER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NET Power Inc. - NPWR

NEW ORLEANS, June 04, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against NET Power Inc. ("Net …

Arctic Wolf Expands into Singapore to Meet Rising Demand for AI-Powered Security Operations

Arctic Wolf Expands into Singapore to Meet Rising Demand for AI-Powered Security Operations

EDEN PRAIRIE, Minn., June 04, 2025 (GLOBE NEWSWIRE) -- Arctic Wolf®, a global leader in security operations, today announced its official launch in Singapore, marking the latest milestone in its ongoing expansion across the Asia-Pacific region. Trusted by …

ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. - OGN

ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. - OGN

NEW ORLEANS, June 04, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Organon …

Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million

Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, RUSSIA, BELARUS, OR ANY …

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA

NEW ORLEANS, June 04, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 15, 2025 to file lead plaintiff applications in a securities class action lawsuit against Iovance …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions